Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

DyNAbind GmbH

DyNAbind is a Dresden-based, privately held company offering drug discovery products and partnership based on its proprietary Dynamic DNA-Encoded Library (D-DEL) platform. DyNAbind is a spin-out from the lab of Prof. Yixin Zhang at the TU Dresden. Company development began in 2015 under an EXIST-Forschungstransfer grant, with foundation in 2017. *

 

Period Start 2017-05-08 established
Products Industry Dynamic DNA-Encoded Library (D-DEL) technology platform
  Industry 2 drug discovery technology
Persons Person Thompson, Michael (Mike) (DyNAbind GmbH 201705– Managing Director (CEO) + Co-Founder)
  Person 2 Höfgen, Norbert (DyNAbind GmbH 201705– Managing Director (COO) + Co-Founder)
     
Region Region Dresden
  Country Germany
  Street 47 Tatzberg
  City 01307 Dresden
  Tel +49-351-446-91536
    Address record changed: 2019-06-02
     
Basic data Employees A: 1 to 10 (2018-12-22)
     
    * Document for �About Section�: High-Tech Gründerfonds Management GmbH. (5/7/19). "Press Release: Drug Discovery Technology Start-up DyNAbind Secures Seed Financing".
     
   
Record changed: 2019-07-03

Advertisement

Picture [LSBNL] Life-Sciences-Benelux.com – The Business Web Portal 600x86px

More documents for DyNAbind GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top